Get short, timely messages from S. Morgan.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @ScienceGap.

Get updates via SMS by texting follow ScienceGap to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

ScienceGap

  1. On Cancer, "We're not waging a single war against a single enemy. It is literally 100s of diseases" but we're winning! http://bit.ly/mOhgnz 10:34 AM Jun 14th, 2011 via TweetDeck
  2. Pharmacogenomics & personalized medicine will hopefully become common clinical tools in the near future: http://shar.es/HjenX 10:21 AM Jun 14th, 2011 via TweetDeck
  3. The US Dept of Health and Human Services updated the list of carcinogens! New carcinogens to watch out for: http://bit.ly/jQ8QNS 3:05 PM Jun 13th, 2011 via TweetDeck
  4. It was great catching up with an old colleague who now works at Celgene La Jolla earlier today. 8:36 PM Jun 10th, 2011 via UberSocial
  5. THX! RT @brianreid: #BestofASCO Best Posters: TPS146 (@scientre), 10080 (@ScienceGap), & TPS227 (@Novartis) for the use of QR codes #ASCO11 10:05 AM Jun 8th, 2011 via UberSocial
  6. SUCCEED phase 3 trial of #ridaforolimus vs placebo as maintenance therapy: CBR 40.6% (rida) vs 28.6% (placebo) #sarcoma #asco11 (tweet 4/4) 2:50 PM Jun 6th, 2011 via UberSocial
  7. SUCCEED phase 3 trial of #ridaforolimus vs placebo as maintenance therapy: OS, HR 0.88 (21.4 vs 19.2 month; not stat sig) #sarcoma #asco11 2:49 PM Jun 6th, 2011 via UberSocial
  8. SUCCEED phase 3 trial #ridaforolimus vs placebo as maintenance therapy: PFS, HR 0.72 (17.7 vs 14.6 wks, p<0.0001) #sarcoma #asco11 2:48 PM Jun 6th, 2011 via UberSocial
  9. Dr. Sant Chawla showed SUCCEED phase 3 trial of #ridaforolimus mTOR inhibitor vs placebo as maintenance therapy as follows #sarcoma #ASCO11 2:46 PM Jun 6th, 2011 via UberSocial
  10. Patrick Schoffski presented phase 2 of cixutumumab (anti IGF-1R antibody) in #sarcoma: modestly active #asco11 2:31 PM Jun 6th, 2011 via UberSocial
  11. I understand 1 may have 2 present so-called "busy" slides every once in a while, but why present & point out 3 busy slides in a row #ASCO11 2:31 PM Jun 6th, 2011 via UberSocial
  12. Dr. Scott Scheutze showed results of phase II of sirolimus (mTOR inhibitor) and cyclophosphamide: not promising combo in #sarcoma #asco11 2:19 PM Jun 6th, 2011 via UberSocial
  13. Dr Shreys. Patel is a rock star! He gave an outstanding presentation on the evolving landscape of treatment of soft-tissue #sarcoma #asco11 2:04 PM Jun 6th, 2011 via UberSocial
  14. Brivanib (randomized phase 2) and pazopanib tphase 3) show very promising clinical benefit in soft-tissue #sarcoma #asco11 1:59 PM Jun 6th, 2011 via UberSocial
  15. Thx @brianreid. abstract 10080 poster contains QR code pointing to http://bit.ly/jyc1Q8 where one can send email or download poster #ASCO11 12:40 PM Jun 6th, 2011 via UberSocial
  16. I put 1 on my poster allowing poster download RT @mtmdphd @mobilelaird @brianreid: wave of the future at #asco11? http://yfrog.com/hs8tompj 11:15 AM Jun 6th, 2011 via UberSocial
  17. Great conversation at #asco11 tweetup event. Sorry I had to leave early. 4:33 PM Jun 5th, 2011 via UberSocial
  18. Efficacy summary of Ipilimumab+DTIC vs Placebo+DTIC (sorry for picture quality) phase 3 in #melanoma #asco11 http://lockerz.com/s/108069352 1:46 PM Jun 5th, 2011 via UberSocial
  19. Vemurafenib is superior to DTIC for primary endpoints (OS, HR 0.37; PFS, HR 0.26) and ORR (~47% vs 5.5%). Exciting for #melanoma #asco11 1:30 PM Jun 5th, 2011 via UberSocial
  20. Many reacted positively to the QR Code I included on my poster that allowed them to email me and/or download poster. I recommend it #ASCO11 12:29 PM Jun 5th, 2011 via UberSocial